Managed care pharmacists can help optimize outcomes in patients with age-related eye disease by addressing concerns regarding affordability of therapy, instructing patients on proper eye drop instillation, and evaluating the effects of different therapies. Ophthalmologists and optometrists should take part in managed care formulary discussions to help achieve optimal patient care.
Managed care pharmacists can help optimize outcomes in patients with age-related eye disease by addressing concerns regarding affordability of therapy, instructing patients on proper eye drop instillation, and evaluating the effects of different therapies. Ophthalmologists and optometrists should take part in managed care formulary discussions to help achieve optimal patient care.
A satellite symposium that focused on the latest management strategies and managed care pharmacy considerations for patients with various age-related eye conditions was recently presented at the Academy of Managed Care Pharmacy 2012 Educational Conference.
The live meeting, “Managed Care and the Aging Eye: Pharmacy Implications for Improving Treatment and Quality of Life,” was designed to enhance managed care pharmacists’ understanding of the latest treatment trends for eye conditions such as dry eye syndrome, glaucoma, and retinal disease.
Michelle Hessen, OD, instructor of ophthalmology at the Wilmer Eye Institute, Johns Hopkins Hospital, presented an overview of conditions related to the aging eye. She emphasized the importance of conducting targeted patient screening, explained the steps leading up to diagnosis, and discussed the factors affecting the decision to begin treatment in certain populations. Among the disease states, Dr Hessen concentrated on ocular manifestations of diabetes mellitus, proliferative and nonproliferative diabetic retinopathy, macular edema, retinal vein occlusion, dry eye syndrome, Meibomian gland disease, age-related macular degeneration, and cataracts. A specialist in dry eye syndrome, Dr Hessen dedicated a portion of her presentation to the various treatments available to treat this condition, including lubricants, topical corticosteroids, cyclosporine A, punctal occlusion, and autologous serum tears.
The dry eye treatment of particular interest was the emerging use of therapeutic bandage soft contact lenses made of silicone hydrogel materials. These extended wear contact lenses can assist with ocular surface repair by protecting the cornea from the mechanical friction of eyelids and exposure to external irritants. In addition, the use of PROSE (prosthetic replacement of the ocular surface ecosystem) to reduce dryness symptoms, which involves the use of a tear reservoir for constant lubrication of the corneal surface, was also discussed in great detail and illustrated by examples of case studies.
Sheldon J. Rich, RPh, PhD, adjunct clinical assistant professor at the University of Michigan and Wayne State University and president of SJR Associates, LLC, was also on hand to share his expertise regarding the costs associated with the use of ophthalmic medications.
Ophthalmic drugs are not as easy to manufacture as solid dosing forms, so achieving generic equivalence is more difficult. Besides active ingredient equivalence, Dr Rich explained, drug makers must take into consideration particle size and the properties of suspension and thickening agents, inert ingredients, preservatives, different vehicles, pH adjusters and buffers, and antioxidants in their formulations. Variations in absorption can occur because of tissue integrity, lipophilicity, and chemical characteristics. Bottle differences and “squeezeability” of these bottles can impact dosage size, and variable bottle overfill may cause a patient to require a refill of a product before a health plan will cover it.
Dr Rich noted that the managed care element of assuring optimal ophthalmic care must be considered. Although ophthalmic agents are not among the top drug classes in terms of expenditures, they still have a high cost per patient, and many branded ophthalmic products cost more than $100 per bottle. Dr Rich believes that to successfully manage these products, ophthalmic drug formularies should “open up” more, and there should be different formulary considerations for acute/short-term use agents and long-term use agents. According to Dr Rich, ophthalmologists and optometrists should also be included in the discussion, to achieve optimal patient care.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
A Focus on Women: AUA Best Posters Highlight Female Athletes, Prenatal Care, and Women in Urology
May 9th 2024Three posters from the American Urological Association (AUA) 2024 Annual Meeting focused on urinary incontinence in female athletes, prenatal care for fetuses with spina bifida in California, and the experiences of women residents at the Brady Urological Institute.
Read More
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
A Focus on Women: AUA Best Posters Highlight Female Athletes, Prenatal Care, and Women in Urology
May 9th 2024Three posters from the American Urological Association (AUA) 2024 Annual Meeting focused on urinary incontinence in female athletes, prenatal care for fetuses with spina bifida in California, and the experiences of women residents at the Brady Urological Institute.
Read More
2 Commerce Drive
Cranbury, NJ 08512